Indivior Pharmaceuticals, Inc. INDV

INDV Company Overview

Indivior Pharmaceuticals, Inc. is the principal U.S. operating subsidiary of Indivior PLC, a specialty pharmaceutical company focused on the development and commercialization of medicines to treat substance use disorders and serious mental illnesses. The company operates within the biopharmaceutical and addiction treatment industries, with a primary emphasis on opioid use disorder (OUD). Its business is centered on prescription medications that combine pharmacological innovation with delivery technologies designed to improve adherence and clinical outcomes.

Indivior traces its origins to a 2014 demerger from Reckitt Benckiser Group, where its addiction treatment business had been incubated. Since becoming an independent publicly traded company, Indivior has narrowed its strategic focus on OUD and related disorders, transitioning from legacy products toward long-acting injectable therapies. The company’s positioning is built around established brand recognition in OUD treatment and a portfolio that spans both daily and extended-release formulations.